A novel compound heterozygous mutation of Gitelman's syndrome in Japan, as diagnosed by an extraordinary response of the fractional excretion rate of chloride in the trichlormethiazide loading test

Intern Med. 2012;51(12):1549-53. doi: 10.2169/internalmedicine.51.6727. Epub 2012 Jun 15.

Abstract

Gitelman's syndrome (GS), an inherited disorder due to loss of function of ion channels and transporters such as Na-Cl co-transporter (NCCT) in distal convoluted tubules, is characterized by hypokalemia, hypomagnesemia, hypocalciuria, metabolic alkalosis and hyperreninemic-hyperaldosteronism. A 39-year-old man was admitted to our hospital because of muscle weakness with such intractable disorders. We performed a thiazide-loading test, which revealed a poor response of the fractional excretion rate of chloride compared to healthy subjects. Based on these data, the clinical diagnosis of GS was made. Gene-sequencing analysis revealed compound heterozygous mutations of c.539C > A and c.1844C > T in SLC12A3, which is newly reported in Japanese GS.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Asian People / genetics
  • Base Sequence
  • Chlorides / metabolism
  • DNA Mutational Analysis
  • Female
  • Gitelman Syndrome / diagnosis
  • Gitelman Syndrome / genetics*
  • Gitelman Syndrome / physiopathology
  • Heterozygote
  • Humans
  • Hypokalemia / genetics
  • Hypokalemia / physiopathology
  • Japan
  • Male
  • Mothers
  • Muscle Weakness / genetics
  • Muscle Weakness / physiopathology
  • Receptors, Drug / genetics
  • Solute Carrier Family 12, Member 3
  • Symporters / genetics
  • Trichlormethiazide / administration & dosage

Substances

  • Chlorides
  • Receptors, Drug
  • SLC12A3 protein, human
  • Solute Carrier Family 12, Member 3
  • Symporters
  • Trichlormethiazide